- Home
- CLOV vs YDES Comparison
CLOV vs YDES Comparison
Compare CLOV & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLOV
- YDES
- Stock Information
- Founded
- CLOV 2014
- YDES 2013
- Country
- CLOV United States
- YDES Taiwan
- Employees
- CLOV N/A
- YDES N/A
- Industry
- CLOV Medical Specialities
- YDES
- Sector
- CLOV Health Care
- YDES
- Exchange
- CLOV Nasdaq
- YDES Nasdaq
- Market Cap
- CLOV 1.3B
- YDES 1.1B
- IPO Year
- CLOV N/A
- YDES N/A
- Fundamental
- Price
- CLOV $2.59
- YDES $8.92
- Analyst Decision
- CLOV Strong Buy
- YDES
- Analyst Count
- CLOV 3
- YDES 0
- Target Price
- CLOV $4.23
- YDES N/A
- AVG Volume (30 Days)
- CLOV 11.7M
- YDES 67.2K
- Earning Date
- CLOV 11-04-2025
- YDES 09-30-2025
- Dividend Yield
- CLOV N/A
- YDES N/A
- EPS Growth
- CLOV N/A
- YDES N/A
- EPS
- CLOV N/A
- YDES N/A
- Revenue
- CLOV $1,773,564,000.00
- YDES $510,360.00
- Revenue This Year
- CLOV $40.52
- YDES N/A
- Revenue Next Year
- CLOV $31.46
- YDES N/A
- P/E Ratio
- CLOV N/A
- YDES N/A
- Revenue Growth
- CLOV 32.15
- YDES 45.76
- 52 Week Low
- CLOV $2.12
- YDES $5.30
- 52 Week High
- CLOV $4.87
- YDES $25.00
- Technical
- Relative Strength Index (RSI)
- CLOV 38.58
- YDES N/A
- Support Level
- CLOV $2.48
- YDES N/A
- Resistance Level
- CLOV $3.72
- YDES N/A
- Average True Range (ATR)
- CLOV 0.24
- YDES 0.00
- MACD
- CLOV -0.11
- YDES 0.00
- Stochastic Oscillator
- CLOV 8.33
- YDES 0.00
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.